Breakfast Symposia

Sponsored breakfast symposia are available to registered delegates to attend at no additional cost, and will be held during the programme.

To indicate your interest in attending any of the Industry Breakfast Symposia listed below* please click here

 *(You can also use this link to add clinical skills sessions  and/or social event tickets to your original registration!).

Thursday 5 July 2018
08.00-09.00 (breakfast available 07.30-08.00)

Session 29
Because sound matters – sponsored by Oticon Medical




This symposium will cover latest clinical results and developments of the Oticon Medical implantable systems, including the Neuro cochlear implant system and the Ponto bone anchored system.

Three talks will focus on cochlear implants and the Neuro system. Mr. Anirvan Banerjee will give an update on the experience with the Neuro Zti implant. The latest clinical results from a clinical trial of the Neuro 2 sound processor, showing among many other positives excellent speech-in-noise performance, will be presented by Dr Dan Gnansia. Ms. Rupan Banga will give an update on the benefits of treating the older cochlear implant patients.

For bone anchored devices, Ms Ann-Louise McDermott will present the long-term results of children treated with bone anchored implants, and how the results have improved over time with refined surgical techniques and implant technologies. Understanding patients and supporting the professionals are two of our key values. Based on research and together with professionals, Oticon Medical has developed new tools to help in the important pre-operative evaluation period. These tools, as well as a glimpse into future bone anchored technologies, will be presented by Mr. Marcus Holmberg.

For full details please click here

Session 30
Immuno-Oncology: What do we need to know? – sponsored by Bristol-Myers Squibb




Immunotherapy harnesses the patients own immune system to kill cancer cells. In this hour meeting we will ask experts to explain the different approaches employed and the evidence that has been generated to support practice change.

Immunotherapy is NICE approved for treating head and neck cancer patients. We will learn which patients can be given immunotherapy, and who is likely to benefit from it. We will also hear about new strategies being investigated to tip the balance in favour of the patient, using tobacco plants to treat cancer!

For full details please click here

Session 31
sponsored by Entellus Medical



Session 32
sponsored by Olympus




For full details please click here